Monic R. Drescher

Hematology

1 Medical Center Dr
Lebanon, NH 03756

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 21, 2024

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 12, 2023

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.

Journal: JAMA

Published: June 02, 2023

Showing 1-3 of 3

Last Updated: 09/26/2026